loadpatents
name:-0.013474941253662
name:-0.0081679821014404
name:-0.0017070770263672
Agejas-Chicharro; Francisco Javier Patent Filings

Agejas-Chicharro; Francisco Javier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Agejas-Chicharro; Francisco Javier.The latest application filed is for "novel benzyl sulfonamide compounds useful as mogat-2 inhibitors".

Company Profile
0.6.6
  • Agejas-Chicharro; Francisco Javier - Madrid ES
  • Agejas-Chicharro; Francisco Javier - Alcobendas ES
  • Agejas-Chicharro; Francisco Javier - Alcobnedas ES
  • Agejas-Chicharro; Francisco Javier - AlcobnedasMadrid
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors
Grant 9,416,138 - Agejas-Chicharro , et al. August 16, 2
2016-08-16
Novel Benzyl Sulfonamide Compounds Useful As Mogat-2 Inhibitors
App 20150284404 - Agejas-Chicharro; Francisco Javier ;   et al.
2015-10-08
Compounds and methods for modulating FXR
Grant 8,153,624 - Genin , et al. April 10, 2
2012-04-10
Cyclopropyl compounds
Grant 8,063,079 - Bueno Melendo , et al. November 22, 2
2011-11-22
Pyridyl derivatives and their use as mGlu5 antagonists
Grant 7,915,424 - Agejas-Chicharro , et al. March 29, 2
2011-03-29
Compounds and methods for modulating FX-receptors
Grant 7,863,302 - Bell , et al. January 4, 2
2011-01-04
Cyclopropyl Compounds
App 20100160395 - Bueno Melendo; Ana Belen ;   et al.
2010-06-24
Compounds And Methods For Modulating Fxr
App 20100152166 - Genin; Michael James ;   et al.
2010-06-17
Morpholine derivatives as norepinephrine reuptake inhibitors
Grant 7,595,315 - Gallagher , et al. September 29, 2
2009-09-29
Compounds and Methods for Modulating Fx-Receptors
App 20080306125 - Bell; Michael Gregory ;   et al.
2008-12-11
Pyridyl Derivatives and Their Use as Mglu5 Antagonists
App 20080194647 - Agejas-Chicharro; Francisco Javier ;   et al.
2008-08-14
Morpholine derivatives as norepinephrine reuptake inhibitors
App 20070060585 - Gallagher; Peter Thaddeus ;   et al.
2007-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed